High-resolution epitope mapping and characterization of SARS-CoV-2 antibodies in large cohorts of subjects with COVID-19.


Journal

Communications biology
ISSN: 2399-3642
Titre abrégé: Commun Biol
Pays: England
ID NLM: 101719179

Informations de publication

Date de publication:
22 11 2021
Historique:
received: 25 02 2021
accepted: 22 10 2021
entrez: 23 11 2021
pubmed: 24 11 2021
medline: 15 12 2021
Statut: epublish

Résumé

As Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) continues to spread, characterization of its antibody epitopes, emerging strains, related coronaviruses, and even the human proteome in naturally infected patients can guide the development of effective vaccines and therapies. Since traditional epitope identification tools are dependent upon pre-defined peptide sequences, they are not readily adaptable to diverse viral proteomes. The Serum Epitope Repertoire Analysis (SERA) platform leverages a high diversity random bacterial display library to identify proteome-independent epitope binding specificities which are then analyzed in the context of organisms of interest. When evaluating immune response in the context of SARS-CoV-2, we identify dominant epitope regions and motifs which demonstrate potential to classify mild from severe disease and relate to neutralization activity. We highlight SARS-CoV-2 epitopes that are cross-reactive with other coronaviruses and demonstrate decreased epitope signal for mutant SARS-CoV-2 strains. Collectively, the evolution of SARS-CoV-2 mutants towards reduced antibody response highlight the importance of data-driven development of the vaccines and therapies to treat COVID-19.

Identifiants

pubmed: 34811480
doi: 10.1038/s42003-021-02835-2
pii: 10.1038/s42003-021-02835-2
pmc: PMC8608966
doi:

Substances chimiques

Antibodies, Viral 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1317

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States

Investigateurs

Kelly Anastasio (K)
Michael H Askenase (MH)
Natasha C Balkcom (NC)
Maria Batsu (M)
Santos Bermejo (S)
Kristina Brower (K)
Molly L Bucklin (ML)
Staci Cahill (S)
Yiyun Cao (Y)
Michael Chiorazzi (M)
Caitlin J Chun (CJ)
Rupak Datta (R)
Giuseppe DeIuliis (G)
Coriann E Dorgay (CE)
Rebecca Earnest (R)
John Fournier (J)
Bertie Geng (B)
Ryan Handoko (R)
William Khoury-Hanold (W)
Roy Herbst (R)
Lynda Knaggs (L)
Maxine Kuang (M)
Sarah Lapidus (S)
Zitong Lin (Z)
Peiwen Lu (P)
Tianyang Mao (T)
Anjelica Martin (A)
Irene Matos (I)
David McDonald (D)
Maksym Minasyan (M)
Adam J Moore (AJ)
Nida Naushad (N)
Allison Nelson (A)
Jessica Nouws (J)
Angela Nunez (A)
Hong-Jai Park (HJ)
Xiaohua Peng (X)
Alexander James Robertson (AJ)
Tyler Rice (T)
Kadi-Ann Rose (KA)
Wade Schulz (W)
Lorenzo Sewanan (L)
Lokesh Sharma (L)
Denise Shepard (D)
Julio Silva (J)
Michael Simonov (M)
Mikhail Smolgovsky (M)
Nicole Sonnert (N)
Ariktha Srivathsan (A)
Yvette Strong (Y)
Codruta Todeasa (C)
Jordan Valdez (J)
Sofia Velazquez (S)
Pavithra Vijayakumar (P)
Elizabeth B White (EB)
Alice Zhao (A)

Informations de copyright

© 2021. The Author(s).

Références

Autoimmun Rev. 2020 Aug;19(8):102597
pubmed: 32535093
Nat Med. 2020 Nov;26(11):1691-1693
pubmed: 32929268
Elife. 2020 May 26;9:
pubmed: 32452762
Glob Chall. 2017 Jan 10;1(1):33-46
pubmed: 31565258
Cell. 2020 Oct 29;183(3):739-751.e8
pubmed: 32991842
N Engl J Med. 2020 Sep 10;383(11):1085-1087
pubmed: 32706954
Science. 2020 Aug 21;369(6506):1010-1014
pubmed: 32540901
EBioMedicine. 2020 Aug;58:102911
pubmed: 32711254
Int J Infect Dis. 2020 May;94:154-155
pubmed: 32179137
Nat Commun. 2020 Nov 26;11(1):6013
pubmed: 33243994
J Virol. 2018 Apr 27;92(10):
pubmed: 29514901
Science. 2020 Dec 11;370(6522):1339-1343
pubmed: 33159009
ACS Med Chem Lett. 2020 Aug 17;11(9):1667-1670
pubmed: 32934770
Emerg Infect Dis. 2020 Dec;26(12):2974-2978
pubmed: 32857691
Nature. 2021 Mar;591(7849):293-299
pubmed: 33494095
J Med Virol. 2006 Jan;78(1):1-8
pubmed: 16299724
Nat Rev Immunol. 2020 Nov;20(11):645-646
pubmed: 33024283
Nat Immunol. 2020 Oct;21(10):1293-1301
pubmed: 32807944
Clin Infect Dis. 2021 Sep 7;73(5):e1208-e1211
pubmed: 33270134
J Neurol. 2021 Mar;268(3):751-757
pubmed: 32734353
Nat Med. 2020 Jun;26(6):845-848
pubmed: 32350462
Science. 2020 Jun 12;368(6496):1163
pubmed: 32527804
Function (Oxf). 2020;1(2):zqaa024
pubmed: 33201937
Cell. 2020 Dec 10;183(6):1735
pubmed: 33306958
Science. 2020 Aug 21;369(6506):890-891
pubmed: 32820099
Proc Natl Acad Sci U S A. 2021 Jun 8;118(23):
pubmed: 34021074
Immunity. 2020 Sep 15;53(3):524-532.e4
pubmed: 32783920
Science. 2020 Nov 27;370(6520):
pubmed: 32994364
Science. 2020 Aug 21;369(6506):1014-1018
pubmed: 32540904
Cell. 2020 Nov 12;183(4):968-981.e7
pubmed: 32966765
Sci Rep. 2016 Aug 02;6:30312
pubmed: 27481573
Nucleic Acids Res. 2017 Jan 4;45(D1):D158-D169
pubmed: 27899622
J Virol. 2014 Dec;88(23):13769-80
pubmed: 25231316
J Mol Biol. 2020 Sep 4;432(19):5212-5226
pubmed: 32710986
Cell Mol Immunol. 2020 Oct;17(10):1095-1097
pubmed: 32895485
Nature. 2020 Sep;585(7825):339-341
pubmed: 32929257
Science. 2020 Oct 23;370(6515):
pubmed: 32972996
Science. 2020 May 22;368(6493):860-868
pubmed: 32291278
Science. 2020 Sep 4;369(6508):
pubmed: 32669297
Euro Surveill. 2017 Mar 30;22(13):
pubmed: 28382917
PLoS One. 2020 Oct 21;15(10):e0241104
pubmed: 33085715
Nature. 2020 Nov;587(7833):270-274
pubmed: 32726801
Nat Struct Mol Biol. 2020 Aug;27(8):763-767
pubmed: 32647346
Front Immunol. 2021 Apr 27;12:625311
pubmed: 33986742
Science. 2020 Oct 2;370(6512):89-94
pubmed: 32753554
Science. 2020 Dec 4;370(6521):1227-1230
pubmed: 33115920
Nature. 2020 Dec;588(7837):327-330
pubmed: 32942285
Neurology. 2020 Sep 29;95(13):559-560
pubmed: 32788251
Clin Infect Dis. 2020 Dec 17;71(10):2688-2694
pubmed: 32497196
Nucleic Acids Res. 2019 Jul 2;47(W1):W636-W641
pubmed: 30976793
Sci Rep. 2020 Mar 24;10(1):5294
pubmed: 32210339
Lancet. 2020 Aug 29;396(10251):603-611
pubmed: 32822564
Rev Med Virol. 2012 Jan;22(1):2-17
pubmed: 21905149
Cell. 2020 Nov 12;183(4):982-995.e14
pubmed: 32991843
Cell. 2021 Apr 1;184(7):1858-1864.e10
pubmed: 33631096
Science. 2020 Oct 30;370(6516):527-529
pubmed: 33055131
Nat Commun. 2020 Jun 1;11(1):2806
pubmed: 32483236
Biostatistics. 2007 Jan;8(1):2-8
pubmed: 16702229
Euro Surveill. 2020 Mar;25(10):
pubmed: 32183930

Auteurs

Winston A Haynes (WA)

Serimmune, Inc., Goleta, CA, USA.

Kathy Kamath (K)

Serimmune, Inc., Goleta, CA, USA.

Joel Bozekowski (J)

Serimmune, Inc., Goleta, CA, USA.

Elisabeth Baum-Jones (E)

Serimmune, Inc., Goleta, CA, USA.

Melissa Campbell (M)

Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.

Arnau Casanovas-Massana (A)

Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.

Patrick S Daugherty (PS)

Serimmune, Inc., Goleta, CA, USA.

Charles S Dela Cruz (CS)

Department of Medicine, Section of Pulmonary and Critical Care Medicine, Yale University School of Medicine, New Haven, CT, USA.

Abhilash Dhal (A)

Serimmune, Inc., Goleta, CA, USA.

Shelli F Farhadian (SF)

Department of Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT, USA.

Lynn Fitzgibbons (L)

Santa Barbara Cottage Hospital, Santa Barbara, CA, USA.

John Fournier (J)

Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.

Michael Jhatro (M)

Serimmune, Inc., Goleta, CA, USA.

Gregory Jordan (G)

Serimmune, Inc., Goleta, CA, USA.

Jon Klein (J)

Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.

Carolina Lucas (C)

Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.

Debra Kessler (D)

New York Blood Center, New York, NY, USA.

Larry L Luchsinger (LL)

New York Blood Center, New York, NY, USA.

Brian Martinez (B)

Serimmune, Inc., Goleta, CA, USA.

M Catherine Muenker (M)

Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.

Lauren Pischel (L)

Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.
Department of Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT, USA.

Jack Reifert (J)

Serimmune, Inc., Goleta, CA, USA.

Jaymie R Sawyer (JR)

Serimmune, Inc., Goleta, CA, USA.

Rebecca Waitz (R)

Serimmune, Inc., Goleta, CA, USA.

Elsio A Wunder (EA)

Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.

Minlu Zhang (M)

Serimmune, Inc., Goleta, CA, USA.

Akiko Iwasaki (A)

Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
Howard Hughes Medical Institute, Chevy Chase, MD, USA.

Albert Ko (A)

Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.

John C Shon (JC)

Serimmune, Inc., Goleta, CA, USA. john.shon@serimmune.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH